InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（5 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
5
T+90 胜率
0%
T+90 平均收益
-16.7%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the detailed record of transactions filed by Seely Lynn, 董事. Insider active across 2 companies, notably Blueprint Medicines Corp. In total, 16 filings have been logged. Breakdown: 1 buy · 5 sells. Total volume traded: €386k. History available since 2 June 2021. The latest transaction was filed on 21 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Seely Lynn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
9,589 股@ US$15.54Common StockSEC:0001327111-26-000006:0
390 股@ US$14.340.0016% mcap1.9% 占其流量Common StockSEC:0001327111-26-000004:0
7,455 股@ US$23.3957.8% 占其流量Common StockSEC:0001327111-26-000002:0
20,000 股0Common StockSEC:0001327111-26-000001:0
412 股@ US$16.115.4% 占其流量Common StockSEC:0001327111-25-000007:0
40,000 股0Common StockSEC:0001415889-25-022747:0
391 股@ US$10.5263.5% 占其流量Common StockSEC:0001415889-25-021694:0
3,902 股Common StockSEC:0001104659-25-069390:0
3,902 股@ US$128.12100.0% 占其流量Common StockSEC:0001415889-25-018082:0
175,000 股@ US$0.6068100.0% 占其流量Common StockSEC:0001415889-25-008509:0
标准退出：2025年6月12日 (T+90)
337,500 股0Common StockSEC:0001415889-25-005768:0
2,242 股0Common StockSEC:0001415889-24-016983:0
200,000 股0Common StockSEC:0001209191-24-003269:0
2,600 股0Common StockSEC:0001415889-23-010262:0
2,600 股0Common StockSEC:0001415889-22-007128:0
2,250 股0Common StockSEC:0001179110-21-006416:0
16 条申报中的 16 条
About Seely Lynn
Seely Lynn is Administrateur at Lyell Immunopharma, Inc. and a director at Blueprint Medicines Corp. He has 14 filings in total. In the 14 most recent sampled filings, buys amount to EUR 97820 and sells to EUR 155951, over the period from 2021-06-04 to 2026-02-12, with the modal transaction nature listed as Attribution.
